
    
      The study will involve up to 30 patients to be enrolled using the FiberNet device during
      clinically indicated percutaneous intervention of SVG and followed through 30 days post
      procedure. Patients will be enrolled at up to 10 Investigative Sites. The study is a
      prospective multi-center registry with sequential enrollment of qualified patients who
      consent to participate and meet all entrance criteria.

      The Lumen Biomedical, Inc. FiberNetÂ® Embolic Protection System is indicated for use as a
      guide wire and embolic protection system to capture and remove embolic material
      (thrombus/debris) produced while performing percutaneous transluminal interventional
      procedures in saphenous vein grafts with reference vessel diameters of 1.75 mm to 7.0 mm.
    
  